Canine vaccine recipients recognize an immunodominant region of the rabies virus glycoprotein

Journal of General Virology

Volumn 83, Issue 11, 2002, Pages 2663-2669

  Johnson, N ^a   Mansfield, K L ^a   Fooks, A R ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; EPITOPE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; RABIES VACCINE; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DOG; IMMUNE RESPONSE; INFECTION PREVENTION; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; RABIES; VIRUS STRAIN;

ANIMALIA; CANIS FAMILIARIS; CANIS LUPUS; ORYCTOLAGUS CUNICULUS; RABIES VIRUS; RNA VIRUSES;

EID: 0036843027     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-11-2663     Document Type: Article

References (23)

1. Anilionis, A., Wunner, W. H. & Curtis, P. J. (1981). Structure of the glycoprotein gene in rabies virus. Nature 294, 275-278.
2. Badrane, H., Bahloul, C., Perrin, P. & Tordo, N. (2001). Evidence for two lyssavirus phylogroups with distinct pathogenicity and immunogenicity. Journal of Virology 75, 3268-3276.
3. Bunschoten, H., Gore, M., Claassen, I. J. T. M., Uytdehaag, F. G. C. M., Dietzschold, B., Wunner, W. H. & Osterhaus, A. D. M. E. (1989). Characterisation of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. Journal of General Virology 70, 291-298.
4. Champion, J. M., Kean, R. B., Rupprecht, C. E., Notkins, A. L., Koprowski, H., Dietzschold, B. & Hooper, D. C. (2000). The development of monoclonal human rabies-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure. Journal of Immunological Methods 231, 81-90.
5. Cliquet, F., Aubert, M. & Sagne, L. (1998). Development of a fluorescent antibody virus neutralisation test (FAVN) for the quantification of rabies-neutralizing antibody. Journal of Immunological methods 212, 79-87.
6. Coll, J. M. (1995). The glycoprotein G of rhabdoviruses. Archives of Virology 140, 827-851.
7. Coulon, P., Derbin, C., Kucera, P., Lafay, F., Prehaud, C. & Flamand, A. (1989). Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative AvO1. Journal of Virology 63, 3550-3554.
8. Coulon, P., Lafay, F. & Flamand, A. (1993). Rabies virus antigenicity: an overview. Onderstepoort Journal of Veterinary Virology 60, 271-275.
9. Dietzschold, B., Wiktor, T. J., Macfarlan, R. & Varrichlo, A. (1982). Antigenic structure of rabies virus glycoprotein: ordering and immunological characterization of the large CNBr cleavage fragments. Journal of Virology 44, 595-602.
10. Dietzschold, B., Wunner, W. H., Tadeusz, J. W., Lopes, D., Lafon, M., Smith, C. L. & Koprowski, H. (1983). Characterization of an antigenic determinant of the rabies glycoprotein that correlates with pathogenicity of rabies virus. Proceedings of the National Academy of Sciences, USA 80, 70-74.
11. Dietzschold, B., Gore, M., Marchadier, D., Niu, H. S., Bunschoten, H. M., Otvos, L. Jr, Wunner, W. H., Ertl, H. C. J., Osterhaus, A. D. M. E. & Koprowski, H. (1990). Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. Journal of Virology 64, 3804-3809.
12. Fooks, T., McElhinney, L. M., Brookes, S. M., Johnson, N., Keene, V., Parsons, G. & Soldan, A. (2002). Rabies antibody testing and the UK Pet Travel Scheme. Veterinary Record 150, 428-430.
13. Gaudin, Y., Ruigrok, R. W. H., Tuffereau, C., Knossow, M. & Flamand, A. (1992). Rabies virus glycoprotein is a trimer. Virology 184, 441-444.
14. Heaton, P. R., Johnstone, P., McElhinney, L. M., Cowley, R., O'Sullivan, E. & Whitby, J. E. (1997). Heminested PCR assay for detection of six genotypes of rabies and rabies-related viruses. Journal of Clinical Microbiology 35, 2762-2766.
15. Hemachuda, T. & Phuapradit, P. (1997). Rabies. Current Opinion in Neurobiology 10, 260-267.
16. Hooper, D. C., Morimoto, K., Bette, M., Weihem, E., Koprowski, H. & Dietzschold, B. (1998). Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. Journal of Virology 72, 3711-3719.
17. Lafay, F., Benmansour, A., Chebli, K. & Flamand, A. (1996). Immunodominant epitopes defined by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites. Journal of General Virology 77, 339-346.
18. Luo, T. R., Minamota, N., Ito, H., Goto, H., Hiraga, S., Ito, N., Sugiyama, M. & Kinjo, T. (1997). A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope. Virus Research 51, 35-41.
19. Ni, Y., Tominaga, Y., Honda, Y., Morimoto, K., Sakamoto, S. & Kawai, A. (1995). Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody Rg719. Microbiology and Immunology 39, 693-702.
20. Prehaud, C., Coulon, P., Lafay, F., Thiers, C. & Flamand, A. (1988). Antigenic site II of rabies virus glycoprotein: structure and role in viral virulence. Journal of Virology 62, 1-7.
21. Seif, I., Coulon, P., Rollin, P. E. & Flamand, A. (1985). Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. Journal of Virology 53, 926-934.
22. Van der Heijden, R. W. J., Langedijk, J. P., Groen, J., UytdeHaag, F. G., Meloen, R. H. & Osterhaus, A.D. (1993). Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein. Journal of General Virology 74, 1539-1545.
23. Walker, P. J. & Kongsuwan, K. (1999). Deduced structural model for animal rhabdovirus glycoproteins. Journal of General Virology 80,